IBD SURVEILLANCE ACROSS IRELAND; DYE-ING TO KNOW WHAT YOU DO

Aims Establish current practice with regards to surveillance and the use of dye spray chromoendoscopy in the Irish IBD cohort.

Methods A survey was distributed to gastroenterology consultants and registrars working in Ireland.

Routine practice surrounding IBD surveillance, use of guidelines, performance of biopsies and use of chromoendoscopy was established.

Results Among the 49 respondents; 60% were male and 52% were consultant gastroenterologists.

Sixty percent had less than 10 years endoscopy experience, whereas 32.5% had 11–25 years.

Responses were identified from 15 hospital sites from secondary and tertiary referral centres across the east,west and north of Ireland.

For 49%, greater than 50% of their practice involved IBD. Among respondents,71% typically surveil IBD patients (where appropriate).

During surveillance colonoscopy, 86% perform random biopsies whereas 14% don’t.

The majority (57%) perform segmental biopsies; 30% serial biopsies every 10 cm and 13% right and left biopsies.

Ninety three percent perform targeted biopsies, typically when a visible mucosal

abnormality or suspicious lesion is seen.

The majority (69%) follow ECCO guidelines, with 29% following the BSG and only 2%follow AGA. No respondents followed ASGE.

Twenty seven percent use white light endoscopy alone whereas 60% (n = 27) occasionally or sometimes do.

Only 5% always perform chromoendoscopy; 44% never do.

Solutions used for chromoendoscopy varied but the majority at 36% (n = 15) use indo-carmine 0.2%, however a large number of respondents were unsure of the concentration.

Conclusions Currently IBD surveillance in Ireland varies in practice. Improved education may enhance incorporation of guidelines into standard of care.